Search
for
Sort by
Research 811–840 of 879
- Hirsutism Beyond PCOS: Genome-wide Evidence for Genetic Factors
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Comprehensive HPLC and UPLC-MS/MS Analysis for the Multi-component Detection of Hair Growth Compounds in Consumer Health Products
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Ophthalmologic Comorbidities in Alopecia Areata
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Real-world evidence in alopecia areata treatment: A narrative review
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Latanoprost
- Medical Remedies for Alopecia